Delivery Order SPE2DB20D3103-SPE2DB25FL6T7

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $128K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $110,891.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX (PF) HEP A/B Vaccine Syringes, a hepatitis A and B combination vaccine, to support federal healthcare programs. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,818.87 firm fixed-price delivery order is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of March 24, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $172,832.91 firm-fixed-price delivery order is for the TWINRIX vaccine, a combination hepatitis A and hepatitis B vaccine. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,788.64 firm fixed-price delivery order is for the TWINRIX VACCINE SYRINGE, a hepatitis A and hepatitis B combination vaccine. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,933.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX VACCINE SYRINGEML, a combination hepatitis A and hepatitis B vaccine, to support various federal government healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company,...
This federal contract award, valued at $65,550.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,274.20 firm fixed-price delivery order is for the supply of TWINRIX vaccines, a vaccine used to prevent hepatitis A and hepatitis B. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $13,656.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine for Hepatitis A and Hepatitis B. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an Ultimate Completion Date of August 28, 2024. It is not designated as a Set-Aside contract, indicating open...
This contract award, valued at $26,997.25, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX vaccine syringes, a vaccine used to prevent hepatitis A and hepatitis B. This is a firm-fixed-price delivery order contract with an ultimate completion date of August 5, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a large Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,048.76 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes to support federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL6T7
    Delivery Order

This federal contract award, valued at $127,579.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the TWINRIX VACCINE SYRINGE, a hepatitis A and hepatitis B combination vaccine, to support federal healthcare programs.

The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also includes a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 1:51 PM